Regulatory combinations partition menopause-treatment responses

This proposed hypothesis asks whether menopause symptoms can signal stable groups that respond differently to treatment, a distinction that could shape long-term care. It proposes that inherited combinations of DNA switches that control gene activity and proteins that assist hormone receptors create these groups, even when symptoms and hormone levels overlap. The decisive test would compare a pre-defined genetic classifier with flexible models that treat response as a continuum. In genetically matched cells given equal hormone exposure, editing the implicated DNA combination should alter hormone-driven gene activity; a sham edit should leave it unchanged. Large samples, replication and a direct link to clinical outcomes would be required.